Skip to navigation Skip to content

Share

Master Page Does Not Exist

    Services

    Master Page Does Not Exist
    1. Ask an MS Navigator

      The Society's MS Navigators help identify solutions and provide access to the resources you are looking for. Call 1-800-344-4867 or see "More info" to contact us online.

    2. UCSF Leads International Study on the Microbiome and Multiple Sclerosis

      The international MS microbiome study (iMSMS, www.imsms.org) may shed light on the role the gut flora plays in MS.

    3. Clinical Trial: Ofatumumab versus teriflunomide (UC Davis)

      A randomized, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of ofatumumab versus teriflunomide in patients with relapsing multiple sclerosis (COMB157G2301)

      Sacramento, CA 95817

    Resources

    Master Page Does Not Exist
    1. Promising MS Research - Recorded Webcast

      Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

    2. Clinical Trials: Solving One Piece of the MS Puzzle Part 1 (video)

      This video features part one of a series that discusses research efforts for multiple sclerosis and clinical trials.

    3. Clinical Trials in MS

      Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

    4. Find Clinical Trials

      Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

    5. From Clinical Trials to Treatments

      This presentation is: From Clinical Trials to Treatments.

    6. Symptomatic Treatment Trials

      This document outlines Symptomatic Treatment Trials.

    7. Veterans with Multiple Sclerosis

      The National MS Society is collaborating with the Department of Veteran’s Affairs MS Centers of Excellence to support improved care and support services for veterans with multiple sclerosis and their families.

    8. How the National MS Society Makes Funding Decisions (Teleconference Recording)

      Original Air Date: March 22, 2011 Presenter: Dr. Patricia O'Looney Research in MS is progressing at a remarkable rate, with more potential therapies in the pipeline than at any other time in history. The National MS Society is a driving force of MS research. Learn how far we've come, where we're going, and what the Society is doing to move toward a world free of MS.

    9. MS Research Update (Teleconference Recording)

      Original Air Date: October 6, 2011

    10. Exploring Every Potential Research Solution (Teleconference Recording)

      Original air date: November 13, 2013. Learn from leading MS researchers and clinicians in California on what’s in the pipeline and on the horizon. Dr. Lilyana Amezcua from USC is defining genetic and ethnic contributions in MS, with an emphasis on Hispanic descent. Dr. Nancy Sicotte from Cedars-Sinai is examining MRI images to search for the underlying cause of MS-related depression. Dr. Emanuelle Waubant from UCSF is focused on the association of bacteria in the digestive tract and MS.

    11. MS Top 10 Therapies Research Update (Teleconference recording)

      Recorded June 5, 2014. During this teleconference participants will: Understand the risks and benefits of different treatment options; Learn about new treatments on the horizon; Understand how different treatment options compare to each other. The speaker, Dr. Graesser, specializes in MS and in addition to general neurology cases, she also provides care for movement disorders, headaches, and neurologic disorders in pregnancy.

    12. MS Research Using Vision (OCT) Testing: Anti-LINGO-1 (video)

      Neuro-opthalmologist Tariq Bhatti, MD, at Duke University Eye Center, discusses the use of optical coherence tomography (OCT) in evaluating multiple sclerosis (MS) progression and the effects of treatments - namely anti-LINGO-1.

Share

Master Page Does Not Exist